Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Non-cash Items (2023 - 2025)

Upstream Bio has reported Non-cash Items over the past 3 years, most recently at $21.4 million for Q4 2025.

  • Quarterly results put Non-cash Items at $21.4 million for Q4 2025, down 69.97% from a year ago — trailing twelve months through Dec 2025 was $21.4 million (down 69.97% YoY), and the annual figure for FY2025 was $21.4 million, up 973.61%.
  • Non-cash Items for Q4 2025 was $21.4 million at Upstream Bio, down from $23.0 million in the prior quarter.
  • Over the last five years, Non-cash Items for UPB hit a ceiling of $71.3 million in Q4 2024 and a floor of $2.2 million in Q1 2025.
  • Median Non-cash Items over the past 3 years was $23.0 million (2025), compared with a mean of $26.0 million.
  • Biggest five-year swings in Non-cash Items: soared 1433.26% in 2024 and later crashed 69.97% in 2025.
  • Upstream Bio's Non-cash Items stood at $4.6 million in 2023, then soared by 1433.26% to $71.3 million in 2024, then crashed by 69.97% to $21.4 million in 2025.
  • The last three reported values for Non-cash Items were $21.4 million (Q4 2025), $23.0 million (Q3 2025), and $24.4 million (Q2 2025) per Business Quant data.